Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
I.YangS
The study had two objectives: to demonstrate PF3944 could achieve continued weight loss when switching from weekly to monthly subcutaneous injections and maintain its efficacy while reducing the dosing frequency four-fold and to demonstrate PF3944 could switch to a four-fold equivalent monthly dose while maintaining a well-tolerated and favorable safety profile
A healthcare professional can help you determine the appropriate calorie deficit for continued weight loss
The evidence for divided dosing over single daily dosing is not established in humans
US$ 27.67
US$ 28.54
US$ 25.91
US$ 29.49
US$ 20.64
US$ 25.71
US$ 27.76
US$ 23.56
US$ 23.78
